Caroline Happold
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.
Journal: Journal of neurochemistry
Published: June 30, 2017
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Journal: Journal of neuro-oncology
Published: June 28, 2017
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma.
Journal: Neuro-oncology
Published: May 06, 2017
Reply to F. Felix et al and M.F. Fay et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 15, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Journal: Neuro-oncology
Published: March 28, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 21, 2016
New insights into acquired temozolomide resistance in glioblastoma?
Journal: Brain : a journal of neurology
Published: November 25, 2015
Management of diffusely infiltrating glioma in the elderly.
Journal: Current opinion in oncology
Published: September 24, 2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells.
Journal: PloS one
Published: April 01, 2015
Corticosteroid use in neuro-oncology: an update.
Journal: Neuro-oncology practice
Published: July 04, 2014
Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells.
Journal: Molecular cancer therapeutics
Published: February 15, 2014
Last Updated: 09/26/2026